These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36633038)

  • 1. [ADHD medication to improve academic performance?].
    van den Berk-Bulsink MJE; Bakker M; van der Horst M
    Ned Tijdschr Geneeskd; 2023 Jan; 167():. PubMed ID: 36633038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Real-world" effectiveness of methylphenidate in improving the academic achievement of Attention-Deficit Hyperactivity Disorder diagnosed students-A systematic review.
    de Faria JCM; Duarte LJR; Ferreira LA; da Silveira VT; Menezes de Pádua C; Perini E
    J Clin Pharm Ther; 2022 Jan; 47(1):6-23. PubMed ID: 34254328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
    Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
    Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misuse of Methylphenidate.
    Clemow DB
    Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive mechanisms of methylphenidate in ADHD: Do improvements in sustained attention mediate behavioral improvements in the natural environment?
    Merrill BM; Raiker JS; Evans SW; Gnagy EM; Pelham WE
    Child Neuropsychol; 2021 May; 27(4):425-446. PubMed ID: 33525966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS; Chen SJ; Chou WJ; Cheng H; Tang CS; Chang HL; Tzang RF; Wu YY; Huang YF; Chou MC; Liang HY; Hsu YC; Lu HH; Huang YS
    J Clin Psychiatry; 2008 Jan; 69(1):131-40. PubMed ID: 18312048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Attention-Deficit/Hyperactivity Disorder and Methylphenidate Treatment on the Adult Auditory Temporal Order Judgment Threshold.
    Fostick L
    J Speech Lang Hear Res; 2017 Jul; 60(7):2124-2128. PubMed ID: 28672285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental perceived benefits of OROS-methylphenidate treatment for the child with attention-deficit/hyperactivity disorder and for parents themselves.
    Kim JW; Park S; Kim BN; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    Pharmacopsychiatry; 2013 Jun; 46(4):137-46. PubMed ID: 23364873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Management of Adherence to Prescribed Stimulants in College Students With ADD/ADHD.
    Gould ON; Doucette C
    J Atten Disord; 2018 Feb; 22(4):349-355. PubMed ID: 27016530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
    Nielsen NP; Wiig EH; Bäck S; Gustafsson J
    Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.
    Riggs PD; Winhusen T; Davies RD; Leimberger JD; Mikulich-Gilbertson S; Klein C; Macdonald M; Lohman M; Bailey GL; Haynes L; Jaffee WB; Haminton N; Hodgkins C; Whitmore E; Trello-Rishel K; Tamm L; Acosta MC; Royer-Malvestuto C; Subramaniam G; Fishman M; Holmes BW; Kaye ME; Vargo MA; Woody GE; Nunes EV; Liu D
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):903-14. PubMed ID: 21871372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.
    Bogle KE; Smith BH
    Curr Drug Abuse Rev; 2009 May; 2(2):157-76. PubMed ID: 19630746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.